EUVIMEDSkopri EUVIMED
KohortenstudieOpen access · CC BY-NC 4.0

Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study

Laurence Lalanne, Perrine Roux iD, Cécile Donadille, Laelia Briand Madrid, Isabelle Célerier, Carole Chauvin, Naomi Hamelin, Charlotte Kervran, Gwenaëlle Maradan, Marc Auriacombe iD, Marie Jauffret-Roustide iD, COSINUS Study Group

Addiction · 2024-01 · 119 (1) · 180-199

DOI: 10.1111/add.16320 ↗

At a glance

Kohortenstudie in Addiction, published online on 2023-09-24. Written by Laurence Lalanne and 11 co-authors. Institution: INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS…. Major MEDLINE topics: Substance Abuse, Intravenous, Drug Users, HIV Infections, Hepatitis C. Cited 19 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives, French National Institute for Health and Medical Research, Institut National de la Santé et de la Recherche Médicale.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aims

The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment‐sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid agonist treatment (OAT).

Design

The COhort to identify Structural and INdividual factors associated with drug USe (COSINUS cohort) was a 12‐month longitudinal study of 665 people who inject drugs (PWID), conducted in Bordeaux, Marseille, Paris and Strasbourg. We used data from face‐to‐face interviews at enrolment and at 6‐month and 12‐month visits. Setting and participants The participants were recruited in harm reduction programmes in Bordeaux and Marseille and in DCRs in Strasbourg and Paris. Participants were aged more than 18 years, French‐speaking and had injected substances the month before enrolment.

Measurements

We measured the impact of DCR exposure on injection equipment sharing, HCV testing and the use of medications for opioid use disorder, after adjustment for significant correlates. We used a two‐step Heckman mixed‐effects probit model, which allowed us to take into account the correlation of repeated measures and to control for potential bias due to non‐randomization between the two groups (DCR‐exposed versus DCR‐unexposed participants).

Findings

The difference of declared injection equipment sharing between PWID exposed to DCRs versus non‐exposed was 10% (1% for those exposed versus 11% for those non‐exposed, marginal effect = −0.10; 95% confidence interval = −0.18, −0.03); there was no impact of DCRs on HCV testing and OAT.

Conclusions

In the French context, drug consumption rooms appear to have a positive impact on at‐risk practices for infectious diseases such as human immunodeficiency virus (HIV) and hepatitis C virus.

Subjects

MeSH terms (MEDLINE)

Substance Abuse, IntravenousDrug UsersHIV InfectionsHepatitis CHumansHepacivirusCohort StudiesLongitudinal StudiesRisk-Taking

Author keywords

At-risk practicesHCVHIVcohort studiesdrug consumption roomsdrug policyevaluationharm reduction

Authors and institutions

  • INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
  • Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
  • ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France.
  • Centre d'étude des Mouvements Sociaux (Inserm U1276/CNRS UMR8044/EHESS), Paris, France.
  • Addiction Team, SANPSY, CNRS UMR 6033, Bordeaux, France.

ORCID profiles: Perrine Roux, Marc Auriacombe, Marie Jauffret-Roustide

Funding

  • Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives
  • French National Institute for Health and Medical Research
  • Institut National de la Santé et de la Recherche Médicale

Cite

APA

Lalanne, L., Roux, P., Donadille, C., Briand Madrid, L., Célerier, I., Chauvin, C., Hamelin, N., Kervran, C., Maradan, G., Auriacombe, M., Jauffret-Roustide, M., & COSINUS Study Group (2024). Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study. Addiction, 119(1), 180-199. https://doi.org/10.1111/add.16320

Vancouver

Lalanne L, Roux P, Donadille C, Briand Madrid L, Célerier I, Chauvin C, et al. Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study. Addiction. 2024;119(1):180-199. doi:10.1111/add.16320

BibTeX
@article{Lalanne2024,
  author = {Lalanne, Laurence and Roux, Perrine and Donadille, Cécile and Briand Madrid, Laelia and Célerier, Isabelle and Chauvin, Carole and Hamelin, Naomi and Kervran, Charlotte and Maradan, Gwenaëlle and Auriacombe, Marc and Jauffret-Roustide, Marie and COSINUS Study Group, COSINUS Study Group},
  title = {Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study},
  journal = {Addiction},
  year = {2024},
  volume = {119},
  number = {1},
  pages = {180--199},
  doi = {10.1111/add.16320}
}
Start for free →